Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concomitant Omacetaxine Mepesuccinate and Azacitidine for Patients With Previously Untreated High Grade Myelodysplastic Syndromes

NCT03564873 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT03564873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03564873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concomitant Omacetaxine Mepesuccinate and Azacitidine for Patients With Previously Untreated High Grade Myelodysplastic Syndromes
Lead sponsor
University of Colorado, Denver
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
September 17, 2018
Completion date
June 30, 2027
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high grade myelodysplastic syndromes